. Author manuscript; available in PMC: 2016 Nov 17.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):967–971. doi: 10.1016/j.ijrobp.2008.08.001

Table 1.

Critical organ dose-volume limits for central and superior non–small-cell lung cancer lesions using stereotactic body radiation therapy to deliver 50 Gy in four fractions

Organ	Volume, cc	Total dose (dose per fraction), Gy
Esophagus	≤ 1	35 (8.8)
Esophagus	≤ 10	30 (7.5)
Brachial plexus^*	Any point	<40
	≤ 1	35 (8.8)
	≤ 10	30 (7.5)
Trachea	≤ 1	35 (8.8)
Trachea	≤ 10	30 (7.5)
Main bronchus and bronchial tree	≤ 1	40 (10)
Main bronchus and bronchial tree	≤ 10	35 (8.8)
Heart	≤ 1	40 (10)
Heart	≤ 10	35 (8.8)
Whole lung (right & left, excluding gross tumor volume)	V20	<20%
	V10	<30%
	V5	<40%
Major vessels	≤ 1	40 (10)
Major vessels	≤ 10	35 (8.8)
Skin (to 5 mm)	≤ 1	40 (10)
Skin (to 5 mm)	≤ 10	35 (8.8)
Spinal cord	≤ 1	20 (5)
Spinal cord	≤ 10	15 (3.8)

Added after a case of neuropathy, as shown in Figure 3.